This inventor holds 1 USPTO granted patent. Top assignees: Shanghai Aryl Pharmtech Co., Ltd., Zhejiang Hisun Pharmaceutical Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 4 
1 out of 5 Years Active: 2026
Title: Chengcai Lin and His Pharmaceutical Patent
Introduction
Chengcai Lin is an inventor associated with Taizhou, China, and pharmaceutical research. His patent work includes a quinazoline derivative proposed for therapeutic use, particularly as a SOS1 inhibitor.
Latest Patents
Lin is credited with 1 patent: “Quinazoline Derivative, or Preparation Method Therefor and Use Thereof.” The invention concerns a substituted quinazoline derivative, methods for preparing it, pharmaceutically acceptable salts, and pharmaceutical compositions containing the derivative. It also describes the compound and its compositions for medical use, particularly as SOS1 inhibitors.
Career Highlights
Lin has been associated with Zhejiang Hisun Pharmaceutical Co., Ltd. and Shanghai Aryl Pharmtech Co., Ltd. His patent reflects work in medicinal chemistry and the development of potential therapeutic agents.
Collaborations
Lin’s named coworkers include Panpan Zhang and Chaoying Cheng.
Conclusion
Chengcai Lin’s recorded patent centers on a substituted quinazoline compound and its potential application as a SOS1 inhibitor, connecting his work with pharmaceutical research in China.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile